JPMorgan Increases Stake in WUXI APPTEC (02359) by Approximately 872,100 Shares at HK$106.32 per Share

WuXi AppTec Completes Sale of WuXi Clinical and WuXi MedKey to Hillhouse

BRIEF-Blackrock's Long Position In H-Shares Of Wuxi Apptec Decreases To 4.57% On Dec 9 - HKEX

BlackRock's Long Position in H-Shares of WuXi AppTec Decreases to 4.57% on Dec 9 From 5.24% - HKEX

Qatar Investment Authority Reduces Stake in WUXI APPTEC (02359) by 869,400 Shares at HK$102.77 per Share

Behind Wuxi AppTec's "High Growth" Q3 Report: Non-Recurring Gains Account for 80% of Profits, Domestic Business Stagnates

Biotech Stocks Surge: Wuxi Bio and Wuxi Apptec Lead Gains

JPMorgan Increases Stake in WUXI APPTEC (02359) by Approximately 736,509 Shares at HK$102.49 per Share

Wuxi Apptec's Capital Conundrum Amid GLP-1 Boom

BRIEF-Blackrock's Long Position In H-Shares Of Wuxi Apptec Increases To 5.48% On Nov 5 - HKEX

BlackRock's Long Position in H-Shares of WuXi AppTec Increases to 5.48% on Nov 5 From 4.80% - HKEX

Wuxi Apptec's Earnings "Big Rebound": Did Li Ge Show Off Financial Tricks?

CCB International Raises WUXI APPTEC (02359) Target Price to HK$131, Maintains "Outperform" Rating

BOCI Raises WUXI APPTEC (02359) Target Price to HK$127 on Strong Q3 Results

Oct 29 Shareholding Changes: Hangzhou Oxygen Plans to Increase Stake, While 11 Stocks Including Wuxi Apptec Plan Reductions (Table)

BRIEF-Wuxi AppTec's Shareholders To Cut 2% A-Shares

Refile-WuXi AppTec Says Shareholders Plan to Unload up to Combined 2% a-Shares in Co (Clarifies Shareholders to Cut a-Shares)

WuXi AppTec Says Shareholders Plan to Unload up to Combined 2% Stakes in Co

Performance, Efficiency, and Strategy in Harmony: WUXI APPTEC (02359) CRDMO Model Flourishes in Q3 2025

BRIEF-NEOM Signs Strategic MoU With Wuxi AppTec To Advance Saudi's Biotechnology Sector